Pharsight

Topicort generic

Topicort is a drug owned by Taro Pharms that contains desoximetasone as an active ingredient. It was initially authorized for market use on 11 April, 2013.

When will Topicort generic be available?

The generic versions of Topicort are expected to be released after 01 September, 2028 once the last patent expires.

Topicort uses

desoximetasone, the active ingredient in Topicort, makes it an effective treatment for plaque psoriasis in patients 18 years of age or older.

Topicort patent expiration

Topicort has a total of 2 drug patents, none of which have expired. The expiration date of the last patent is on 01 September, 2028. Below are the details of the patent:

Topicort dosage

Want to ask something?